Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Agex Therapeutics Inc (NY: AGE ) N/A UNCHANGED Last Price Updated: 8:00 PM EDT, Mar 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Agex Therapeutics Inc AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE February 27, 2024 From Kahn Swick & Foti, LLC Via Business Wire AgeX Therapeutics Reports Third Quarter 2023 Financial Results November 14, 2023 From AgeX Therapeutics, Inc. Via Business Wire AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE September 05, 2023 From Kahn Swick & Foti, LLC Via Business Wire AGE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AgeX Therapeutics, Inc. Is Fair to Shareholders August 30, 2023 From Halper Sadeh LLC Via Business Wire Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement August 30, 2023 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Reports Second Quarter 2023 Financial Results August 14, 2023 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock July 24, 2023 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock July 21, 2023 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Announces Appeal of NYSE American Determination May 23, 2023 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Reports First Quarter 2023 Financial Results May 12, 2023 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Receives Stock Exchange Deficiency Letter April 26, 2023 From AgeX Therapeutics , Inc. Via Business Wire AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results March 31, 2023 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements November 25, 2022 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Reports Third Quarter 2022 Financial Results November 10, 2022 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Reports Second Quarter 2022 Financial Results August 12, 2022 From AgeX Therapeutics, Inc. Via Business Wire Dr. Joanne Hackett Appointed Chairperson of AgeX Board of Directors May 18, 2022 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Reports First Quarter 2022 Financial Results May 13, 2022 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results March 29, 2022 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders December 14, 2021 From AgeX Therapeutics, Inc. Via Business Wire Braeden Lichti: The Business of Anti-Aging and Rejuvenation Biotechnology December 31, 2021 VANCOUVER, British Columbia - Dec. 31, 2021 - PRLog -- 2020-07-30: Scientists now have a better understanding into the aging process, giving us a better explanation of the cellular changes that lead... Via PRLog Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001 November 30, 2021 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Receives Stock Exchange Deficiency Letter November 23, 2021 From AgeX Therapeutics , Inc. Via Business Wire AgeX Therapeutics Reports Third Quarter 2021 Financial Results November 12, 2021 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Reports Second Quarter 2021 Financial Results August 13, 2021 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics and LyGenesis Terminate Merger Negotiations July 23, 2021 From AgeX Therapeutics, Inc. Via Business Wire AgeX Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update May 17, 2021 From AgeX Therapeutics Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.